Selected research
Industry Research
cfDNA Testing Industry Research Report 2026
Market perspective
The global cfDNA Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the cfDNA Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the cfDNA Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the cfDNA Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of cfDNA Testing include Illumina, Oncogenomics, Revvity, CareDx, Natera, BillionToOne, Inc., Yourgene Health, ARUP Laboratories and Roche. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global cfDNA Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to cfDNA Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
cfDNA Testing Market by Company
Illumina
Oncogenomics
Revvity
CareDx
Natera
BillionToOne, Inc.
Yourgene Health
ARUP Laboratories
Roche
cfDNA Testing Segment by Type
Targeted Sequencing
Whole Genome Sequencing
cfDNA Testing Segment by Application
Prenatal Testing
Oncology
Organ Transplant Monitoring
Others
cfDNA Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global cfDNA Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of cfDNA Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of cfDNA Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of cfDNA Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Targeted Sequencing
- Whole Genome Sequencing
Applications
- Prenatal Testing
- Oncology
- Organ Transplant Monitoring
- Others
Companies covered
- Illumina
- Oncogenomics
- Revvity
- CareDx
- Natera
- BillionToOne, Inc.
- Yourgene Health
- ARUP Laboratories
- Roche
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 cfDNA Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Targeted Sequencing
- 2.2.3 Whole Genome Sequencing
- 2.3 cfDNA Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Prenatal Testing
- 2.3.3 Oncology
- 2.3.4 Organ Transplant Monitoring
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 cfDNA Testing Breakdown Data by Type
- 3.1 Global cfDNA Testing Historic Market Size by Type (2021-2026)
- 3.2 Global cfDNA Testing Forecasted Market Size by Type (2027-2032)
4 cfDNA Testing Breakdown Data by Application
- 4.1 Global cfDNA Testing Historic Market Size by Application (2021-2026)
- 4.2 Global cfDNA Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global cfDNA Testing Market Perspective (2021-2032)
- 5.2 Global cfDNA Testing Growth Trends by Region
- 5.2.1 Global cfDNA Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 cfDNA Testing Historic Market Size by Region (2021-2026)
- 5.2.3 cfDNA Testing Forecasted Market Size by Region (2027-2032)
- 5.3 cfDNA Testing Market Dynamics
- 5.3.1 cfDNA Testing Industry Trends
- 5.3.2 cfDNA Testing Market Drivers
- 5.3.3 cfDNA Testing Market Challenges
- 5.3.4 cfDNA Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top cfDNA Testing Players by Revenue
- 6.1.1 Global Top cfDNA Testing Players by Revenue (2021-2026)
- 6.1.2 Global cfDNA Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global cfDNA Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of cfDNA Testing Head Office and Area Served
- 6.4 Global cfDNA Testing Players, Product Type & Application
- 6.5 Global cfDNA Testing Manufacturers Established Date
- 6.6 Global cfDNA Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America cfDNA Testing Market Size (2021-2032)
- 7.2 North America cfDNA Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America cfDNA Testing Market Size by Country (2021-2026)
- 7.4 North America cfDNA Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe cfDNA Testing Market Size (2021-2032)
- 8.2 Europe cfDNA Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe cfDNA Testing Market Size by Country (2021-2026)
- 8.4 Europe cfDNA Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific cfDNA Testing Market Size (2021-2032)
- 9.2 Asia-Pacific cfDNA Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific cfDNA Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific cfDNA Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America cfDNA Testing Market Size (2021-2032)
- 10.2 South America cfDNA Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America cfDNA Testing Market Size by Country (2021-2026)
- 10.4 South America cfDNA Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa cfDNA Testing Market Size (2021-2032)
- 11.2 Middle East & Africa cfDNA Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa cfDNA Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa cfDNA Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Illumina
- 12.1.1 Illumina Company Information
- 12.1.2 Illumina Business Overview
- 12.1.3 Illumina Revenue in cfDNA Testing Business (2021-2026)
- 12.1.4 Illumina cfDNA Testing Product Portfolio
- 12.1.5 Illumina Recent Developments
- 12.2 Oncogenomics
- 12.2.1 Oncogenomics Company Information
- 12.2.2 Oncogenomics Business Overview
- 12.2.3 Oncogenomics Revenue in cfDNA Testing Business (2021-2026)
- 12.2.4 Oncogenomics cfDNA Testing Product Portfolio
- 12.2.5 Oncogenomics Recent Developments
- 12.3 Revvity
- 12.3.1 Revvity Company Information
- 12.3.2 Revvity Business Overview
- 12.3.3 Revvity Revenue in cfDNA Testing Business (2021-2026)
- 12.3.4 Revvity cfDNA Testing Product Portfolio
- 12.3.5 Revvity Recent Developments
- 12.4 CareDx
- 12.4.1 CareDx Company Information
- 12.4.2 CareDx Business Overview
- 12.4.3 CareDx Revenue in cfDNA Testing Business (2021-2026)
- 12.4.4 CareDx cfDNA Testing Product Portfolio
- 12.4.5 CareDx Recent Developments
- 12.5 Natera
- 12.5.1 Natera Company Information
- 12.5.2 Natera Business Overview
- 12.5.3 Natera Revenue in cfDNA Testing Business (2021-2026)
- 12.5.4 Natera cfDNA Testing Product Portfolio
- 12.5.5 Natera Recent Developments
- 12.6 BillionToOne, Inc.
- 12.6.1 BillionToOne, Inc. Company Information
- 12.6.2 BillionToOne, Inc. Business Overview
- 12.6.3 BillionToOne, Inc. Revenue in cfDNA Testing Business (2021-2026)
- 12.6.4 BillionToOne, Inc. cfDNA Testing Product Portfolio
- 12.6.5 BillionToOne, Inc. Recent Developments
- 12.7 Yourgene Health
- 12.7.1 Yourgene Health Company Information
- 12.7.2 Yourgene Health Business Overview
- 12.7.3 Yourgene Health Revenue in cfDNA Testing Business (2021-2026)
- 12.7.4 Yourgene Health cfDNA Testing Product Portfolio
- 12.7.5 Yourgene Health Recent Developments
- 12.8 ARUP Laboratories
- 12.8.1 ARUP Laboratories Company Information
- 12.8.2 ARUP Laboratories Business Overview
- 12.8.3 ARUP Laboratories Revenue in cfDNA Testing Business (2021-2026)
- 12.8.4 ARUP Laboratories cfDNA Testing Product Portfolio
- 12.8.5 ARUP Laboratories Recent Developments
- 12.9 Roche
- 12.9.1 Roche Company Information
- 12.9.2 Roche Business Overview
- 12.9.3 Roche Revenue in cfDNA Testing Business (2021-2026)
- 12.9.4 Roche cfDNA Testing Product Portfolio
- 12.9.5 Roche Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst